Macular Edema
📧 Sign up to get email alerts when something new happens for Macular Edema.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-11-13EMA Authorised: Afiveg (aflibercept) — STADA Arzneimittel AG
The EMA has authorised Afiveg, an aflibercept product by STADA, for multiple retinal conditions including wet age-related macular degenerati…
-
EMA approval · 2025-11-12EMA Authorised: Eyluxvi (aflibercept) — Biolitec pharma Limited Zweigniederlassung Jena
EMA authorised Eyluxvi (aflibercept) from Biolitec pharma Limited Zweigniederlassung Jena for treatment of wet age-related macular degenerat…
-
EMA approval · 2025-11-07EMA Authorised: Baiama (aflibercept) — Formycon AG
EMA authorised Baiama, a biosimilar aflibercept from Formycon AG, for multiple retinal diseases including wet age-related macular degenerati…
-
EMA approval · 2025-11-04EMA Authorised: Vgenfli (aflibercept) — Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
The EMA authorized Vgenfli (aflibercept) from Polpharma for multiple retinal diseases, including wet age-related macular degeneration, macul…
-
EMA approval · 2025-10-24EMA Authorised: Ozurdex (dexamethasone) — AbbVie Deutschland GmbH & Co. KG
The European Medicines Agency authorised Ozurdex (dexamethasone intravitreal implant) for the treatment of macular edema and uveitis. The de…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema [Phase 1]
This clinical trial update indicates that the investigational drug MS-553 is in Phase 1 testing for diabetic retinopathy with central-involv…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery [NA]
This clinical trial is recruiting to compare the efficacy of three NSAID eye drops—bromfenac 0.09%, nepafenac 0.3%, and diclofenac 0.1%—in p…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE [Phase 3]
A Phase 3 clinical trial to evaluate intravitreal KSI-101 for macular edema secondary to inflammation is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy [NA]
This ongoing clinical trial at Pomeranian Medical University Szczecin is evaluating retinal parameters in patients with epiretinal membrane …
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon [EARLY_Phase 1]
This clinical trial update describes an early-phase (Phase 1) study evaluating suprachoroidal administration of triamcinolone acetonide for …
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period [Phase 4]
Phase 4 trial comparing post-intravitreal injection pain scores when using loteprednol etabonate, bromfenac sodium, or artificial tears in p…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Minimal Vitrectomy Surgery for Epiretinal Membrane [NA]
A clinical trial from Peking Union Medical College Hospital is currently recruiting to study minimal vitrectomy surgery for epiretinal membr…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of ranibizumab 10 mg/mL injections for diabetic macular edema is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients [Phase 1]
A completed Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of IVT MHU650 in macular edema patients. The trial also …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Vitrectomy Combined With Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane With Macular Oedema [NA]
A clinical trial evaluating the combination of vitrectomy with an intravitreal dexamethasone implant for idiopathic epiretinal membrane with…
-
EMA withdrawal · 2025-04-14EMA Application withdrawn: Skojoy (aflibercept) — Amgen Technology (Ireland) UC
EMA has withdrawn the marketing authorization application for Skojoy (aflibercept) submitted by Amgen Technology (Ireland) UC. The applicati…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Implementation of the Intravitreal Injection Administered by Nurses
A clinical trial update describes implementing intravitreal injections administered by nurses, potentially expanding access in studies for m…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies [NA]
A clinical trial evaluating micropulsed laser treatment for macular edema associated with inherited retinal dystrophies, currently recruitin…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy
This clinical trial investigates the mechanical properties of the internal limiting membrane and evaluates intraoperative use of Brilliant B…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection [NA]
Clinical trial update reporting functional and anatomical outcomes of the dexamethasone intravitreal implant for resistant macular edema due…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO [Phase 2]
Phase 2 study evaluating the usability of the SB11 prefilled syringe in subjects with wet age-related macular degeneration or macular edema …
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Incidence of Macular Edema in a Uveitis Population
The document describes a clinical trial investigating the incidence of macular edema in patients with non-infectious uveitis; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Effectiveness of Periocular Drug Injection in CATaract Surgery [Phase 3]
Phase 3 trial evaluating periocular drug injection in cataract surgery was terminated; the update does not provide final results.
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion [Phase 4]
Phase 4 trial update evaluating Eylea (aflibercept) and Lucentis (ranibizumab) for macular edema due to branch retinal vein occlusion. The t…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin [Phase 2, Phase 3]
A Phase 2/3 clinical trial is investigating intravitreal bevacizumab with and without oral curcumin for diabetic macular edema and macular e…